These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 668190

  • 1. Spontaneous lymphocyte proliferation and depressed cellular immunity in Hodgkin's disease.
    Shiftan TA, Caviles AP, Mendelsohn J.
    Clin Exp Immunol; 1978 Apr; 32(1):144-52. PubMed ID: 668190
    [Abstract] [Full Text] [Related]

  • 2. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.
    Hillinger SM, Herzig GP.
    J Clin Invest; 1978 Jun; 61(6):1620-7. PubMed ID: 149140
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Depressed T cell proliferative responses in Hodgkin's disease: role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide.
    Fisher RI, Bostick-Bruton F.
    J Immunol; 1982 Oct; 129(4):1770-4. PubMed ID: 6980949
    [Abstract] [Full Text] [Related]

  • 5. Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity.
    Passwell J, Levanon M, Davidsohn J, Ramot B.
    Clin Exp Immunol; 1983 Jan; 51(1):61-8. PubMed ID: 6572580
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immune status of untreated patients with Hodgkin's disease and prognosis.
    Björkholm M, Wedelin C, Holm G, Ogenstad S, Johansson B, Mellstedt H.
    Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
    [Abstract] [Full Text] [Related]

  • 8. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ, Hansen JA, Bloomfield CD, Good RA.
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
    Churchill WH, Rocklin RR, Moloney WC, David JR.
    Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
    [No Abstract] [Full Text] [Related]

  • 11. Monocyte function in Hodgkin's disease.
    Holm G, Björkholm M, Johansson B, Mellstedt H, Lindemalm C.
    Clin Exp Immunol; 1982 Jan; 47(1):162-8. PubMed ID: 7094420
    [Abstract] [Full Text] [Related]

  • 12. Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.
    Rühl H, Vogt W, Bochert G, Schmidt S, Moelle R, Schaoua H.
    Clin Exp Immunol; 1975 Jan; 19(1):55-65. PubMed ID: 128426
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Hodgkin's disease--immunological aspects].
    Plat M, Frank KH, Fleischer J, Plat U, Koslowski R.
    Allerg Immunol (Leipz); 1988 Jan; 34(3):139-58. PubMed ID: 3057835
    [Abstract] [Full Text] [Related]

  • 15. Studies of cell subpopulations mediating mitogen hyporesponsiveness in patients with Hodgkin's disease.
    Sibbitt WL, Bankhurst AD, Williams RC.
    J Clin Invest; 1978 Jan; 61(1):55-63. PubMed ID: 304068
    [Abstract] [Full Text] [Related]

  • 16. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
    Levo Y, Rotter V, Ramot B.
    Biomedicine; 1975 Jun 30; 23(6):198-200. PubMed ID: 1082352
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease. Their relationship to immune function.
    Spinozzi F, Velardi A, Rambotti P, Losito A, Zampi I, Cernetti C, Gerli R, Martelli MF, Grignani F.
    J Clin Lab Immunol; 1983 Oct 30; 12(2):87-92. PubMed ID: 6644793
    [Abstract] [Full Text] [Related]

  • 19. Immunological capacity of lymphocytes from untreated patients with Hodgkin's disease evaluated in mixed lymphocyte culture.
    Björkholm M, Holm G, Mellstedt H, Pettersson D.
    Clin Exp Immunol; 1975 Dec 30; 22(3):373-7. PubMed ID: 131665
    [Abstract] [Full Text] [Related]

  • 20. Spontaneous production of an inhibitor in vitro lymphocyte migration by lymphocytes from patients with Hodgkin's disease and mycosis fungoides.
    Skopińska-Rónzewska E, Zółtowska A, Dziewulska-Bokiniec A.
    Arch Immunol Ther Exp (Warsz); 1982 Dec 30; 30(1-2):57-62. PubMed ID: 6756337
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.